MCID: KWS002
MIFTS: 70

Kawasaki Disease malady

Categories: Genetic diseases, Rare diseases, Cardiovascular diseases, Bone diseases, Immune diseases

Aliases & Classifications for Kawasaki Disease

About this section

Aliases & Descriptions for Kawasaki Disease:

Name: Kawasaki Disease 52 11 48 25 54 70 50 38 2 13
Mucocutaneous Lymph Node Syndrome 11 48 24 25 54 70 39 68
Acute Febrile Mucocutaneous Lymph Node Syndrome 11 25 27
Infantile Polyarteritis 24 70 68
Kawasaki Syndrome 48 25 2
Kawasaki Disease, Susceptibility to 24 12
 
Kd 25 2
Bulbo-Spinal Atrophy, X-Linked 68
Acute Febrile Mcls 11
Kawasaki's Disease 11
Mlns 11
Kwd 70

Characteristics:

Orphanet epidemiological data:

54
kawasaki disease:
Inheritance: Multigenic/multifactorial; Age of onset: Adolescent,Adult,Childhood,Infancy; Age of death: normal life expectancy

Classifications:



External Ids:

OMIM52 611775
Disease Ontology11 DOID:13378
ICD1030 M30.3
ICD9CM32 446.1
MeSH39 D009080
NCIt45 C34825
Orphanet54 ORPHA2331
ICD10 via Orphanet31 M30.3

Summaries for Kawasaki Disease

About this section
OMIM:52 Kawasaki disease is an acute, self-limited vasculitis of infants and children characterized by prolonged fever... (611775) more...

MalaCards based summary: Kawasaki Disease, also known as mucocutaneous lymph node syndrome, is related to hemophagocytic lymphohistiocytosis and cervicitis, and has symptoms including proteinuria, glossitis and skin rash. An important gene associated with Kawasaki Disease is ITPKC (Inositol-Trisphosphate 3-Kinase C), and among its related pathways are Validated transcriptional targets of AP1 family members Fra1 and Fra2 and Cell adhesion_ECM remodeling. Affiliated tissues include body, heart and lymph node, and related mouse phenotypes are liver/biliary system and respiratory system.

Disease Ontology:11 A lymphadenitis characterized by swelling of cervical lymph nodes in infants and young children and inflammation of medium-sized blood vessels located in body, has symptom fever, has symptom congestion of ocular conjunctivae, has symptom reddening of lips, has symptom reddening of oral cavity, has symptom protuberance of tongue papillae and has symptom edema of extremities.

Genetics Home Reference:25 Kawasaki disease is a sudden and time-limited (acute) illness that affects infants and young children. Affected children develop a prolonged fever lasting several days, a skin rash, and swollen lymph nodes in the neck (cervical lymphadenopathy). They also develop redness in the whites of the eyes (conjunctivitis) and redness (erythema) of the lips, lining of the mouth (oral mucosa), tongue, palms of the hands, and soles of the feet.

NIH Rare Diseases:48 Kawasaki disease is a condition that involves inflammation of the blood vessels. It is typically diagnosed in young children, but older children and adults can also develop this condition. Kawasaki disease begins with a fever that lasts at least 5 days. Other classic symptoms may include red eyes, lips, and mouth; rash; swollen and red hands and feet; and swollen lymph nodes. Sometimes the condition affects the coronary arteries (which carry oxygen-rich blood to the heart). This can lead to serious heart problems. Kawasaki disease occurs most often in people of Asian and Pacific Island descent. The cause of Kawasaki disease is unknown. An infection along with genetic factors may be involved. Treatment includes intravenous gamma globulin and high doses of aspirin in a hospital setting. Prognosis generally is very good, but in cases of heart complications it depend in the severity of the coronary disease.  Last updated: 1/17/2017

MedlinePlus:38 Kawasaki disease is a rare childhood disease. it makes the walls of the blood vessels in the body become inflamed. it can affect any type of blood vessel, including the arteries, veins, and capillaries. no one knows what causes kawasaki disease. symptoms include high fever that lasts longer than 5 days swollen lymph nodes in the neck a rash on the mid-section and genital area red, dry, cracked lips and a red, swollen tongue red, swollen palms of the hands and soles of the feet redness of the eyes kawasaki disease can't be passed from one child to another. there is no single test. to diagnose it, doctors look at the signs and symptoms. they may also use an echocardiogram or other tests. it is mainly treated with medicines. rarely, medical procedures and surgery also may be used for children whose coronary arteries are affected. kawasaki disease can't be prevented. however, most children who develop the disease fully recover - usually within weeks of getting signs and symptoms. further problems are rare. nih: national heart, lung, and blood institute

UniProtKB/Swiss-Prot:70 Kawasaki disease: An acute, self-limited vasculitis of infants and children characterized by prolonged fever unresponsive to antibiotics, polymorphous skin rash, erythema of the oral mucosa, lips, and tongue, erythema of the palms and soles, bilateral conjunctival injection, and cervical lymphadenopathy.

Wikipedia:71 Kawasaki disease is a disease in which blood vessels throughout the body become inflamed. The most... more...

Related Diseases for Kawasaki Disease

About this section

Diseases related to Kawasaki Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 380)
idRelated DiseaseScoreTop Affiliating Genes
1hemophagocytic lymphohistiocytosis30.9IL10, IL6, TNF
2cervicitis30.8ELANE, MMP9, TIMP1
3lupus erythematosus30.6ALB, IL10, SELE
4ischemic heart disease30.5ALB, CRP, IL6
5coronary artery disease30.2CCL2, CRP, IL6, NPPB, SELE
6short bowel syndrome30.2CCL2, CRP, IL6, TNF
7adult respiratory distress syndrome30.0CRP, IL6, MMP9, NPPB, TNF
8atherosclerosis30.0CCL2, IL10, IL6, MMP3, MMP9, TNF
9pyelonephritis29.9CRP, IL6, MMP3, NPPB, TNF
10alopecia29.7ALB, CCL2, CRP, IL10, IL6, TNF
11systemic lupus erythematosus29.5ALB, CCL2, CRP, FCGR2A, IL10, IL6
12rheumatoid arthritis28.9CCL2, CRP, IL10, IL6, MMP3, MMP9
13asthma28.8ELANE, IL10, IL6, MMP9, SELE, SELL
14myocardial infarction28.6ALB, CCL2, CRP, IL10, IL6, MMP3
15abl1 kd-related altered drug metabolism11.8
16macrophage activation syndrome11.2
17kniest dysplasia11.2
18spinal and bulbar muscular atrophy of kennedy11.2
19piepkorn karp hickok syndrome10.8IL10, TNF
20panner disease10.8CRP, IL6, TNF
21scrub typhus10.8ALB, TNF
22rhizomelic dysplasia, scoliosis, and retinitis pigmentosa10.8MMP3, MMP9
236q terminal deletion syndrome10.8IL10, TNF
24epstein-barr virus hepatitis10.8CRP, IL6, TNF
25large cell carcinoma with rhabdoid phenotype10.8CRP, MMP9, TNF
26cartilage disease10.8ALB, CRP, TNF
27islet cell tumor10.8CRP, IL6, TNF
28paraneoplastic polyneuropathy10.8CRP, IL6, TNF
29atrophic vulva10.8ALB, CRP, IL6
30mechanical lagophthalmos10.8CRP, IL6, TNF
31ethmoid sinus adenoid cystic carcinoma10.8IL10, IL6, TNF
32early congenital syphilis10.7CRP, IL6, TNF
33antidepressant type abuse10.7ALB, CRP, IL6
34orbital lymphangioma10.7IL10, IL6, TNF
35meninges hemangiopericytoma10.7FCGR2A, IL10, TNF
36cervix erosion10.7CRP, IL6, TNF
37scn8a encephalopathy10.7IL10, IL6, TNF
38chronic diarrhea due to guanylate cyclase 2c overactivity10.7CRP, IL6, NPPB
39primary biliary cirrhosis10.7IL10, IL6, TNF
40idiopathic central precocious puberty10.7FCGR2A, IL10, TNF
41idiopathic neutropenia10.7CRP, IL10, IL6
42aneurysm of sinus of valsalva10.7CRP, IL6
43antigen-peptide-transporter 2 deficiency10.7CCL2, IL6, TNF
44accessory nerve disease10.7IL10, IL6, TNF
45senile cataract10.7IL10, IL6, TNF
46benign peritoneal mesothelioma10.7CRP, IL6, TNF
47hemoglobinopathy10.7ALB, IL6, NPPB
48vertebral artery insufficiency10.7IL6, NPPB, TNF
49benign lymphoepithelial lesion of salivary gland10.7ALB, IL6, TNF
50aphthous stomatitis10.7CRP, IL6, NPPB

Graphical network of the top 20 diseases related to Kawasaki Disease:



Diseases related to kawasaki disease

Symptoms & Phenotypes for Kawasaki Disease

About this section


Clinical features from OMIM:

611775

Symptoms:

 11 (show all 6)
  • fever
  • congestion of ocular conjunctivae
  • reddening of lips
  • reddening of oral cavity
  • protuberance of tongue papillae
  • edema of extremities

Human phenotypes related to Kawasaki Disease:

 64 54 (show all 45)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 proteinuria64 54 hallmark (90%) Very frequent (99-80%) HP:0000093
2 glossitis64 54 hallmark (90%) Very frequent (99-80%) HP:0000206
3 skin rash64 54 hallmark (90%) Very frequent (99-80%) HP:0000988
4 vasculitis64 54 hallmark (90%) Very frequent (99-80%) HP:0002633
5 lymphadenopathy64 54 hallmark (90%) Very frequent (99-80%) HP:0002716
6 inflammatory abnormality of the eye64 hallmark (90%) HP:0100533
7 recurrent pharyngitis64 54 hallmark (90%) Very frequent (99-80%) HP:0100776
8 cheilitis64 54 hallmark (90%) Very frequent (99-80%) HP:0100825
9 dry skin64 typical (50%) HP:0000958
10 edema64 54 typical (50%) Frequent (79-30%) HP:0000969
11 arthritis64 54 typical (50%) Frequent (79-30%) HP:0001369
12 abnormality of the heart valves64 54 typical (50%) Frequent (79-30%) HP:0001654
13 abnormality of the pericardium64 typical (50%) HP:0001697
14 leukocytosis64 54 typical (50%) Frequent (79-30%) HP:0001974
15 diarrhea64 54 typical (50%) Frequent (79-30%) HP:0002014
16 abdominal pain64 54 typical (50%) Frequent (79-30%) HP:0002027
17 abnormality of temperature regulation64 typical (50%) HP:0004370
18 abnormality of nail color64 54 typical (50%) Frequent (79-30%) HP:0100643
19 ptosis64 54 occasional (7.5%) Occasional (29-5%) HP:0000508
20 behavioral abnormality64 occasional (7.5%) HP:0000708
21 biliary tract abnormality64 occasional (7.5%) HP:0001080
22 meningitis64 54 occasional (7.5%) Occasional (29-5%) HP:0001287
23 congestive heart failure64 54 occasional (7.5%) Occasional (29-5%) HP:0001635
24 abnormality of the myocardium64 occasional (7.5%) HP:0001637
25 coronary artery disease64 occasional (7.5%) HP:0001677
26 nausea and vomiting64 54 occasional (7.5%) Occasional (29-5%) HP:0002017
27 migraine64 54 occasional (7.5%) Occasional (29-5%) HP:0002076
28 restrictive ventilatory defect64 occasional (7.5%) HP:0002091
29 arthralgia64 54 occasional (7.5%) Occasional (29-5%) HP:0002829
30 dilatation of the ascending aorta64 54 occasional (7.5%) Occasional (29-5%) HP:0005111
31 cranial nerve paralysis64 54 occasional (7.5%) Occasional (29-5%) HP:0006824
32 arrhythmia64 54 occasional (7.5%) Occasional (29-5%) HP:0011675
33 aseptic leukocyturia64 54 occasional (7.5%) Occasional (29-5%) HP:0100586
34 conjunctivitis54 Very frequent (99-80%)
35 irritability54 Occasional (29-5%)
36 jaundice54 Occasional (29-5%)
37 fever54
Frequent (79-30%)
38 interstitial pulmonary disease54 Occasional (29-5%)
39 erythema54 Very frequent (99-80%)
40 double outlet right ventricle with subpulmonary ventricular septal defect without pulmonary stenosis54 Occasional (29-5%)
41 hepatitis54 Occasional (29-5%)
42 fatigue54 Frequent (79-30%)
43 myocarditis54 Occasional (29-5%)
44 cholecystitis54 Occasional (29-5%)
45 pericarditis54 Frequent (79-30%)

UMLS symptoms related to Kawasaki Disease:


chest pain, exanthema, pruritus, vasculitic rash, muscular fasciculation, muscle cramp, tremor, facial paresis

MGI Mouse Phenotypes related to Kawasaki Disease according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053709.6ALB, AR, IL10, IL6, SELE, SELL
2MP:00053889.5IL10, IL6, MMP9, MYD88, SELE, SELL
3MP:00053799.3ALB, AR, IL10, IL6, ITPKC, MYD88
4MP:00053859.3AR, CRP, IL10, IL6, MMP9, MYD88
5MP:00020069.0ALB, AR, ELANE, IL10, IL6, MMP9
6MP:00053908.5AR, FCGR2A, IL10, IL6, MMP3, MMP9
7MP:00053978.3AR, ELANE, FCGR2A, IL10, IL6, ITPKC
8MP:00053768.2ALB, AR, CRP, ELANE, IL10, IL6
9MP:00053877.9AR, CCL2, CRP, ELANE, FCGR2A, IL10

Drugs & Therapeutics for Kawasaki Disease

About this section

Drugs for Kawasaki Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 468)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
GalantamineapprovedPhase 4105357-70-09651, 908828, 9651
Synonyms:
(-)-Galanthamine
(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol
1551-02-6
1953-04-4
1dx6
1qti
357-70-0
4-27-00-02184 (Beilstein Handbook Reference)
736-79-8
AC-20240
AC1L1TIM
BIDD:GT0517
BPBio1_000480
BRD-K49481516-004-03-5
BRD-K49481516-004-04-3
BRN 0093736
BSPBio_000436
BSPBio_003416
C08526
CHEBI:42944
CHEMBL659
CID9651
D04292
DivK1c_000590
GNT
Galantamin
Galantamina
Galantamina [INN-Spanish]
Galantamine
Galantamine (USAN/INN)
Galantamine [USAN:INN]
Galantaminum
Galantaminum [INN-Latin]
Galanthamine
Galanthamine hydrobromide
Galanthaminum
 
HMS2089H03
HSDB 7361
IDI1_000590
InChI=1/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1
Jilkon
KBio1_000590
KBio2_001751
KBio2_004319
KBio2_006887
KBio3_002636
KBioGR_001417
KBioSS_001751
LS-71039
Lycoremin
Lycoremine
MolPort-002-521-885
NCGC00024731-02
NINDS_000590
NSC 100058
Prestwick0_000588
Prestwick1_000588
Prestwick2_000588
Prestwick3_000588
Probes1_000055
Probes2_000395
Razadyne ER
Reminyl
Reminyl (TN)
SDCCGMLS-0066737.P001
SMP1_000131
SPBio_002655
STOCK1N-46108
Spectrum3_001738
Spectrum4_000839
Spectrum5_001673
Spectrum_001271
UNII-0D3Q044KCA
galanthamine
2
AlogliptinapprovedPhase 4, Phase 3, Phase 259850649-61-511450633
Synonyms:
2-({6-[(3r)-3-Aminopiperidin-1-Yl]-3-Methyl-2,4-Dioxo-3,4-Dihydropyrimidin-1(2h)-Yl}methyl)benzonitrile
850649-61-5
Alogliptin
Alogliptina
Alogliptine
 
Alogliptinum
CHEMBL376359
CID11450633
MolPort-005-933-065
SYR-322
UNII-JHC049LO86
3
Rivastigmineapproved, investigationalPhase 4, Phase 383123441-03-277991
Synonyms:
(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate
123441-03-2
3-((1S)-1-(Dimethylamino)ethyl)phenyl N-ethyl-N-methylcarbamate
3-((1S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate
3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate
AB1004572
AC1L2U92
BIDD:GT0316
C11766
CHEMBL636
CID77991
Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester
Carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester
D03822
DB00989
ENA 713 free base
 
Ena 713 Free Base
Ethylmethylcarbamic acid 3-((1S)-1-(dimethylamino)ethyl)phenyl ester
Exelon
Exelon Patch
HMS2089H18
I06-2037
LS-172571
MolPort-003-666-662
NCGC00167531-01
Rivastigmine (JAN/USAN/INN)
Rivastigmine Hydrogen Tartrate
Rivastigmine [USAN:INN]
Rivastigmine hydrogen tartrate
SDZ 212-713
UNII-PKI06M3IW0
[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate
m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate
rivastigmine
4
DonepezilapprovedPhase 4, Phase 3, Phase 2280120014-06-43152
Synonyms:
( inverted exclamation markA)-E 2020
1-Benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine
120014-06-4
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one
2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one
AB1004836
AC-6969
AC1L1FAE
AKOS000277311
Aricept
Aricept ODT
C24H29NO3
CHEBI:53289
CHEMBL502
CID3152
D07869
DB00843
Domepezil
Donaz
Donaz (TN)
 
Donepezil
Donepezil (INN)
Donepezil [INN:BAN]
Donepezil hydrochloride
Donepezilo
Donepezilum
Eranz
I06-0343
KBio2_002144
KBio2_004712
KBio2_007280
KBioSS_002144
LS-81819
MolPort-000-881-588
MolPort-003-847-014
NCGC00167537-01
Oprea1_188452
Spectrum5_001662
Spectrum_001664
TL8000531
UNII-8SSC91326P
5
TiclopidineapprovedPhase 4, Phase 345755142-85-35472
Synonyms:
5-((2-Chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine
5-(2-Chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
5-[(2-chlorophenyl)methyl]-4,5,6,7-tetrahydrothieno[3,2-c]pyridine
5-[(2-chlorophenyl)methyl]-6,7-dihydro-4H-thieno[3,2-c]pyridine
55142-85-3
AC-15204
AC1L1KFB
BIDD:PXR0169
BPBio1_000191
BRD-K00603606-003-03-4
BRN 1216802
BSPBio_000173
C07140
C14H14ClNS
CAS-53885-35-1
CHEBI:9588
CHEMBL833
CID5472
D08594
DB00208
EINECS 259-498-5
HMS2089I18
L001108
LS-152434
MLS001201825
MolPort-002-507-849
 
NCGC00016872-01
NCGC00016872-02
NCGC00024361-04
PCR 5332
Prestwick0_000047
Prestwick1_000047
Prestwick2_000047
Prestwick3_000047
SMR000641861
SPBio_002094
STK589340
STOCK5S-54105
Ticlid
Ticlopidin-Puren
Ticlopidin-Puren (TN)
Ticlopidina
Ticlopidina [INN-Spanish]
Ticlopidine (INN)
Ticlopidine HCL
Ticlopidine Hydrochloride
Ticlopidine [INN:BAN]
Ticlopidinum
Ticlopidinum [INN-Latin]
UNII-OM90ZUW7M1
UNM-0000345023
ZINC19594599
ticlopidine
6
Vildagliptinapproved, investigationalPhase 4, Phase 3156274901-16-56918537
Synonyms:
(2S)-(((3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile
(2S)-1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile
1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile
2-Pyrrolidinecarbonitrile, 1-[[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)- (9CI)
274901-16-5
AC1NQOUT
AC1OCFK2
C502012
CHEBI:253127
CHEMBL142703
CHEMBL319819
CID11077541
CID5251896
CID6918537
D07080
DB04876
EQUA
Equa
FT-0082760
Galvu
Galvus
I11-0029
 
Jalra
LAF 237
LAF-237
LAF237
LS-193227
NVP-LAF 237
NVP-LAF-237
NVP-LAF237
SBB066750
UNII-I6B4B2U96P
Vidagliptin (see Vildagliptin)
Vildagliptin
Vildagliptin (JAN/USAN/INN)
Xiliarx
equa
galvus
jalra
laf 237
laf237
nvp-laf-237
nvp-laf237
s
xiliarx
7
EmpagliflozinapprovedPhase 4, Phase 3113864070-44-0
Synonyms:
 
(1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol
1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene
8
Valsartanapproved, investigationalPhase 4291137862-53-460846
Synonyms:
(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
(S)-N-Valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine
(S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine
(s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid
137862-53-4
AC-4543
AC1L1U1M
AC1Q5QIK
Ambap137862-53-4
Aventis brand of valsartan
BIDD:GT0345
BRD-K45158365-001-02-3
BSPBio_003501
Bio-0796
C081489
C24H29N5O3
CEPA brand of valsartan
CGP 48933
CGP-48933
CHEBI:9927
CHEMBL1069
CID60846
CPD000466318
D00400
DB00177
Diovan
Diovan (TN)
Diovan, Valsartan
Esteve brand of valsartan
HMS1922L21
HMS2051L12
HMS2093K22
HSDB 7519
KBio2_002287
KBio2_004855
KBio2_007423
KBio3_003006
KBioGR_001078
KBioSS_002289
 
Kalpress
L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI)
LS-161334
Lacer brand of valsartan
MLS000759423
MLS001424088
Miten
MolPort-002-507-854
MolPort-003-666-608
N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine
N-(P-(O-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine
N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine
N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-L-valine
N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine
Nisis
Nisis||
Novartis brand of valsartan
Provas
S1894_Selleck
SAM001246581
SMR000466318
SPBio_001260
SPECTRUM1505209
Sanol brand of valsartan
Schwarz brand of valsartan
Spectrum2_001120
Spectrum3_001831
Spectrum4_000749
Spectrum5_001582
Spectrum_001796
TL8000869
Tareg
UNII-80M03YXJ7I
Vals
Valsarran
Valsartan (JAN/USAN/INN)
Valsartan [USAN:INN]
valsartan
walsartan
|Tareg
9
DopamineapprovedPhase 4, Phase 2, Phase 3375951-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
10
Telmisartanapproved, investigationalPhase 4, Phase 3264144701-48-465999
Synonyms:
144701-48-4
2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid
4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid
4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid
4'-((4-mehtyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimmidazolyl)methyl)-2-biphenylcarboxylic acid
4'-[(1,4'-Dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid
4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid
4'-[(1,7'-Dimethyl-2'-propyl-1H,3'h-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid
4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid
4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid
AC-2013
AC1L24EB
AC1Q5U7O
Abbott brand of telmisartan
BAY-68-9291
BAY68-9291
BIBR 277
BIBR 277SE
BIBR-277
BIBR-277-SE
BIBR-277SE
BIDD:GT0365
BRD-K73999723-001-02-2
BSPBio_002738
Bay 68-9291
Bio-0103
Boehringer Ingelheim brand of telmisartan
C07710
C084178
C33H30N4O2
CHEBI:9434
CHEMBL1017
CID65999
CPD000466326
D00627
DB00966
Glaxo Wellcome brand of telmisartan
GlaxoSmithKline brand of telmisartan
 
HMS1922P07
HMS2051P16
HMS2090P17
HMS2093M22
HSDB 7590
I06-0281
KBio3_001958
KBioGR_001842
Kinzal
Kinzalmono
L001035
LS-44263
MLS000759432
MLS001076687
Micardis
Micardis (TN)
Micardis HCT
Micardis, Targit, Temax, BIBR277, Telmisartan
MolPort-003-666-621
NCGC00095150-01
NCGC00095150-02
NCGC00095150-03
Pritor
S1738_Selleck
SAM001246602
SMR000466326
SPBio_002131
SPECTRUM1505261
STK624049
Spectrum2_001976
Spectrum3_001089
Spectrum4_001261
Spectrum5_001053
TL8000991
Telmisartan
Telmisartan (JAN/USAN/INN)
Telmisartan [USAN:INN]
UNII-U5SYW473RQ
YM-086
telmisartan
11
AmlodipineapprovedPhase 4, Phase 348688150-42-92162
Synonyms:
()-Amlodipine
(RS)-3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
-3-(ethoxycarbonyl)-5-(methoxycarbonyl)-6-methyl-1,4-dihydropyridine
2-[(2-Aminoethoxy)methyl]-4-(2-chlorophenyl)
3,5-Pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester
3,5-Pyridinedicarboxylic acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester
3-Ethyl 5-methylester, (±)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl ( -)-2-((2-aminoethoxy)methyl)-4-(2-chlorphenyl)-1,4-dihydro-6-methyl-3,5-pyridindicarboxylat
3-Ethyl-5-methyl ( -)-2-((2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(O-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (+-)-2-(2-aminoethoxymethyl)-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-Ethyl-5-methyl (.+/-.)-2-[(2-aminoethoxy)methyl]-4-(o-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate
3-O-ethyl 5-O-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
3-ethyl 5-methyl 2-{[(2-aminoethyl)oxy]methyl}-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
88150-42-9
88150-47-4 (maleate (1:1))
AC-4535
AC1L1D26
AC1Q32ZS
AMLODIPINE BASE
AMVAZ
Ambap88150-42-9
Amlocard
Amlodipine
Amlodipine (INN)
Amlodipine Benzenesulfonate
Amlodipine Besilate
Amlodipine Besylate
Amlodipine Free Base
Amlodipine [INN:BAN]
Amlodipine besilate
Amlodipine besylate
Amlodipine free base
Amlodipino
Amlodipino [Spanish]
Amlodipinum
Amlodipinum [Latin]
Amlodis
Amlopres
Amlor
 
Amvaz
BIDD:GT0810
BRD-A22032524-074-02-4
BRD-A22032524-074-03-2
BSPBio_002727
C06825
CHEBI:2668
CHEMBL1491
CID2162
CPD000469198
Coroval
D07450
DB00381
HMS2052N03
HMS2089H07
I14-0798
Intervask
Istin
KBio3_001947
KBioGR_001643
LS-131183
Lipinox
Lotrel
MLS001401409
MolPort-001-792-963
NCGC00165957-01
NCGC00165957-02
NCGC00165957-03
Norvasc
Norvasc (TN)
Pelmec
R,S)-Amlodipine
Racemic Amlodipine
SAM001246705
SMR000469198
SPBio_000351
Spectrum2_000486
Spectrum3_001004
Spectrum4_001132
Spectrum5_001550
UK-4834011
UNII-1J444QC288
amlodipine
12
Pregabalinapproved, illicit, investigationalPhase 4, Phase 3355148553-50-85486971
Synonyms:
(3S)-3-(aminomethyl)-5-methylhexanoic acid
(R-)-3-isobutyl GABA
(S)-3-(Aminomethyl)-5-methylhexanoic acid
(S)-3-Isobutyl gaba
(S+)-3-isobutyl GABA
121GE001
148553-50-8
3-Isobutyl gaba
3-isobutyl GABA
AC-1158
AC1NUP03
AKOS005145504
C080245
C8H17NO2
CHEBI:236161
CHEMBL1059
CI 1008
CI-1008
CID5486971
 
D02716
DB00230
FT-0080911
HSDB 7530
LS-75191
Lyrica
Lyrica (TN)
MolPort-000-861-733
PD 144723
PD-144723
Pregabalin
Pregabalin (JAN/USAN/INN)
Pregabalin [USAN]
Pregablin
S-(+)-3-isobutylgaba
S1731_Selleck
SBB062901
TL8001062
TOS-BB-0910
UNII-55JG375S6M
13
NorepinephrineapprovedPhase 4, Phase 3, Phase 268351-41-2439260
Synonyms:
(-)-(R)-Norepinephrine
(-)-Arterenol
(-)-Arterenol free base
(-)-NORADRENALINE
(-)-Noradrenaline
(-)-Norepinephrine
(-)-alpha-(Aminomethyl)protocatechuyl alcohol
(R)-(-)-Norepinephrine
(R)-4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
(R)-4-(2-amino-1-Hydroxyethyl)-1,2-benzenediol
(R)-Noradrenaline
(R)-Norepinephrine
1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)- (9CI)
4-(2-Amino-1-hydroxyethyl)-1,2-benzenediol
4-[(1R)-2-Amino-1-hydroxyethyl]-1,2-benzenediol
4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol
4899-05-2
51-40-1 (l-tartrate (1:1))
51-41-2
66197-73-7
A7257_SIGMA
AC1L96ZT
ALBB-006229
Adrenor
Aktamin
Arterenol
BRN 4231961
BSPBio_002079
C00547
CHEBI:18357
CHEMBL1437
CID439260
D-(-)-Noradrenaline
D00076
D53D5E3A-2360-4CA9-8031-6C2CD4062FD5
DB00368
DivK1c_000230
EINECS 200-096-6
HMS1920B08
HMS2089E18
HMS2091J08
HMS500L12
IDI1_000230
KBio1_000230
KBio2_001489
KBio2_004057
KBio2_006625
KBio3_001579
KBioGR_000635
KBioSS_001489
L-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
L-3,4-Dihydroxyphenylethanolamine
L-3,4-dihydroxyphenylethanolamine
L-Arterenol
L-Noradrenaline
L-Norepinephrine
L-alpha-(Aminomethyl)-3,4-dihydroxybenzyl alcohol
L-alpha-(aminomethyl)-3,4-dihydroxybenzyl alcohol
L-arterenol
L-noradrenaline
LS-42676
LT03330026
 
LT4
Levarterenol
Levarterenolo
Levarterenolo [DCIT]
Levoarterenol
Levonor
Levonoradrenaline
Levonorepinephrine
Levophed
NCGC00159406-02
NCGC00159406-03
NCGC00159406-04
NCGC00159406-05
NCGC00159406-06
NCGC00159406-07
NCGC00159406-09
NINDS_000230
Nor adrenalin
Nor adrenalin (TN)
Nor-Epirenan
Nor-adrenaline
Noradrenalin
Noradrenalina
Noradrenalina [Italian]
Noradrenaline
Noradrenaline (JP15)
Noradrenalinum
Norartrinal
Noreinefrina
Noreinefrina [INN-Spanish]
Norepinefrina
Norepinephrine
Norepinephrine (INN)
Norepinephrine Noradrenalin
Norepinephrine [INN:JAN]
Norepinephrine l-Tartrate (1:1)
Norepinephrinum
Norepinephrinum [INN-Latin]
Norepirenamine
PDSP1_001111
PDSP2_001095
SGCUT00123
SPBio_001048
SPECTRUM1500436
STK503776
Spectrum2_001064
Spectrum3_000520
Spectrum4_000078
Spectrum5_001068
Spectrum_001009
Sympathin E
UNII-X4W3ENH1CV
bmse000404
l-1-(3,4-Dihydroxyphenyl)-2-aminoethanol
l-2-Amino-1-(3,4-dihydroxyphenyl)ethanol
nchembio.284-comp2
nchembio.64-comp2
nchembio705-1
noradrenaline
norepinefrina
norepinephrine
norepinephrinum
to_000024
14
Aspirinapproved, vet_approvedPhase 4, Phase 3, Phase 2111250-78-22244
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(ACETYLOXY)benzoic acid
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
2349-94-2
26914-13-6
50-78-2
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. Empirin
A.S.A. empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
ACETYLSALICYLIC ACID
AI3-02956
AIN
AKOS000118884
ASA
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
Acide 2-(acetyloxy)benzoique
Acide acetylsalicylique
Acide acétylsalicylique
Acido O-acetil-benzoico
Acido acetilsalicilico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
Aloxiprimum
Asacard
Asagran
Asatard
Ascoden-30
Aspalon
Aspec
Aspergum
Aspir-Mox
Aspirdrops
Aspirin
Aspirin (JP15/USP)
Aspirin [BAN:JAN]
Aspirina 03
Aspirine
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
BIDD:GT0118
BRN 0779271
Bay-e-4465
Bayer
Bayer Aspirin 8 Hour
Bayer Buffered
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Plus
Benaspir
Bi-prin
Bialpirina
Bialpirinia
Bufferin
C01405
CCRIS 3243
CHEBI:15365
CHEMBL25
CID2244
Caprin
Cardioaspirin
Cardioaspirina
Cemirit
Claradin
Clariprin
Colfarit
Contrheuma retard
Coricidin
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dispril
DivK1c_000555
Dolean pH 8
Duramax
ECM
EINECS 200-064-1
EU-0100038
Easprin
Easprin (TN)
Ecolen
Ecotrin
Empirin
Empirin with Codeine
Endosprin
Endydol
 
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
Extren
Globentyl
Globoid
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
Helicon
I14-7505
IDI1_000555
Idragin
Istopirin
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kapsazal
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
LS-143
Levius
Lopac-A-5376
Lopac0_000038
MLS001055329
MLS001066332
MLS001336045
MLS001336046
Magnecyl
Measurin
Medisyl
Micristin
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
NCI60_002222
NINDS_000555
NSC 27223
NSC27223
NSC406186
Neuronika
Novid
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-Acetoxybenzoate
O-Acetoxybenzoic acid
O-Acetylsalicylic acid
O-Carboxyphenyl acetate
O-accetylsalicylic acid
O-acetylsalicylic acid
PL-2200
Persistin
Pharmacin
Pirseal
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
S-211
SMR000059138
SP 189
SPBio_001838
SPECTRUM1500130
ST075414
Salacetin
Salcetogen
Saletin
Salicylic acid acetate
Salicylic acid, acetate
Salospir
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spectrum_001245
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
Supac
Tasprin
Temperal
Toldex
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII-R16CO5Y76E
UNII=R16CO5Y76E
UNM-0000306102
Vanquish
WLN: QVR BOV1
XAXA
Xaxa
Yasta
ZORprin
aspirin
cMAP_000006
component of Midol
component of Synirin
nchem.859-comp6
o-Acetoxybenzoic acid
o-Carboxyphenyl acetate
o-acetoxybenzoic acid
o-carboxyphenyl acetate
ácido acetilsalicílico
15
rituximabapprovedPhase 41654174722-31-710201696
Synonyms:
AntiCD20
IDEC-102
IDEC-C2B8
 
Ig gamma-1 chain C region
MabThera
Mabthera
Rituxan
rituximab
16
Methylprednisoloneapproved, vet_approvedPhase 4115383-43-26741
Synonyms:
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6alpha-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6-Methylprednisolone
6-alpha-Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-Wyeth
Artisone-wyeth
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
Besonia
Bio-0658
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
LMST02030178
LS-118498
Lemod
M0639_SIGMA
M1665
MEPRDL
MLS000028541
MLS001148159
MLS002207191
Medesone
Medixon
Medlone 21
 
Medrate
Medrol
Medrol (TN)
Medrol Adt Pak
Medrol Dosepak
Medrol adt pak
Medrol dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [DCIT]
Metilprednisolone [Dcit]
Metipred
Metrisone
Metrocort
Metysolon
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
NSC-19987
NSC19987
Nirypan
Noretona
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Prestwick_622
Promacortine
Reactenol
S1733_Selleck
SAM002589984
SMR000058330
SPBio_002377
Sieropresol
Solomet
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
delta(1)-6alpha-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
methylprednisolone
methylprenisolone
17
Prednisoloneapproved, vet_approvedPhase 4115350-24-85755
Synonyms:
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bio-0666
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
CO-Hydeltra
CPD000718761
Co-Hydeltra
Codelcortone
Cordrol
Cortalone
Cotogesic
Cotolone
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
Delta(1)-dehydrohydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Delta-Ef-Cortelan
Delta-Stab
Delta-stab
Deltacortenol
Deltacortril
Deltacortril Enteric
Deltahydrocortisone
Deltasolone
Deltisilone
Depo-Medrol
Derpo PD
Derpo Pd
Dexa-Cortidelt Hostacortin H
Dexa-Cortidelt hostacortin H
Di Adreson F
Di-Adreson F
Di-Adreson-F
Di-adreson F
DiAdresonF
Dicortol
Donisolone
Dydeltrone
EINECS 200-021-7
Eazolin D
Econopred
Econopred Plus
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
HSDB 3385
Hostacortin H
Hydeltra
Hydeltra-Tba
Hydeltrasol
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
I-Pred
Inflamase Forte
Inflamase Mild
K 1557
Key-Pred
Klismacort
LMST02030179
LS-7669
Lentosone
Lite Pred
M-Predrol
 
MLS001304083
MLS002154250
MLS002207037
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone Acetate
Meti-Derm
Meticortelone
Metreton
MolPort-002-507-147
NCGC00179649-01
NSC 9120
NSC9120
NSC9900
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
PRDL
PRED-G
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Predni-Dome
Prednicen
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
Prednisolone (JP15/USP/INN)
Prednisolone (anhydrous)
Prednisolone Acetate
Prednisolone Sodium Phosphate
Prednisolone Tebutate
Prednisolone [INN:BAN:JAN]
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Prestwick_404
Rolisone
S1737_Selleck
SAM002264639
SMR000718761
SPBio_002367
Scherisolon
Solone
Steran
Sterane
Sterolone
Supercortisol
UNII-9PHQ9Y1OLM
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-Hydrogen
Ultracortene-hydrogen
ZINC03833821
component of Ataraxoid
component of K-Predne-Dome
delta(1)-Cortisol
delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
delta-dehydrocortisol
delta-dehydrohydrocortisone
delta-hydrocortisone
prednisolone
18
SaxagliptinapprovedPhase 4, Phase 2, Phase 3126361442-04-811243969
Synonyms:
(1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile
(1S,5S)-2-[2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile
.1.13,7]dec-1-yl)acetyl]-, (1S,3S,5S)- (9CI)
2-Azabicyclo[3.1.0]hexane-3-carbonitrile, 2-[(2S)-amino(3-hydroxytricyclo[3.3
361442-04-8
AC-6008
BMS 477118
BMS 477118-11
 
BMS-477118
BMS-477118-11
CHEBI:460723
CHEMBL385517
CID11243969
DB06335
OPC-262
Onglyza
S1540_Selleck
Saxagliptin
19
LinagliptinapprovedPhase 4, Phase 3137668270-12-010096344
Synonyms:
(R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
(R)-8-(3-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
668270-12-0
BI 1356
BI-1356
BI-1356-BS
CHEBI:49403
 
CHEBI:499873
CHEMBL237500
CID 10096344
CID10096344
Linagliptin
Ondero
Tradjenta
Trajenta
20
Clopidogrelapproved, nutraceuticalPhase 4, Phase 3, Phase 2756120202-66-6, 113665-84-260606
Synonyms:
( )-(S)-Clopidogrel
(+)-(S)-Clopidogrel
(+)-Clopidogrel
(S)-Clopidogrel
(S)-Methyl 2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetate
113665-84-2
AC-19024
AC1L1TKZ
AC1Q41I9
BIDD:GT0284
BRD-K27721098-065-02-9
BSPBio_003211
C16H16ClNO2S
CGE
CHEBI:37941
CHEMBL1771
CID60606
CLOPIDOGREL SULFATE
CPD000550475
Clopidogrel
Clopidogrel (INN)
Clopidogrel (TN)
Clopidogrel [BAN:INN]
Clopidogrel [Ban:Inn]
Clopidogrel [INN:BAN]
Clopidogrel bisulfate
Clopidogrel bisulphate
Clopidogrel sulfate
Clopidogrelum
D07729
DB00758
DivK1c_000787
HMS2090O21
HMS502H09
HSDB 7430
IDI1_000787
 
Isocover
KBio1_000787
KBio2_000545
KBio2_003113
KBio2_005681
KBio3_002431
KBioGR_000689
KBioSS_000545
LS-172232
MLS001165708
MLS001195633
MLS001304711
Methyl (+)-(S)-alpha-(o-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4H)-acetate
MolPort-002-885-817
MolPort-003-845-991
NCGC00163329-02
NINDS_000787
Plavix
Plavix (TN)
SAM002589956
SMR000550475
SPBio_000463
SR 25990
STK580572
STOCK5S-27782
Spectrum2_000512
Spectrum3_001606
Spectrum4_000175
Spectrum_000105
TL8000400
UNII-A74586SNO7
Zyllt
clopidogrel
clopidogrel, (+)(S)-isomer
methyl (2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoate
methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate
nchem.651-comp8
21Hypolipidemic AgentsPhase 4, Phase 2, Phase 12721
22
SerotoninPhase 4, Phase 3, Phase 2356650-67-95202
Synonyms:
3-(2-Aminoethyl)-1H-indol-5-ol
3-(2-Aminoethyl)indol-5-ol
3-(b-Aminoethyl)-5-hydroxyindole
5-HT
5-HTA
5-Hydroxy-3-(b-aminoethyl)indole
 
5-Hydroxy-tryptamine
5-Hydroxyltryptamine
5-Hydroxytriptamine
5-Hydroxytryptamine
Antemovis
DS substance
Enteramin
Enteramine
23Lipid Regulating AgentsPhase 4, Phase 2, Phase 12702
24AngiotensinogenPhase 4, Phase 3, Phase 21161
25glucocorticoidsPhase 4, Phase 3, Phase 24920
26Protective AgentsPhase 4, Phase 3, Phase 2, Phase 17190
27Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 210355
28Hydroxymethylglutaryl-CoA Reductase InhibitorsPhase 4, Phase 2, Phase 11956
29Hormone AntagonistsPhase 4, Phase 3, Phase 212778
30Anticholesteremic AgentsPhase 4, Phase 2, Phase 11983
31Atorvastatin CalciumPhase 4, Phase 2, Phase 1743134523-03-8
32HormonesPhase 4, Phase 3, Phase 213979
33Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 212767
34Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 2, Phase 122776
35Gastrointestinal AgentsPhase 4, Phase 3, Phase 2, Phase 18109
36Angiotensin-Converting Enzyme InhibitorsPhase 4, Phase 3, Phase 2711
37
Angiotensin IIPhase 4, Phase 3, Phase 2116268521-88-0, 11128-99-7172198, 65143
Synonyms:
1-8-Angiotensin I
1-L-Aspasaginyl-5-L-valyl angiotensin octapeptide
Ang II
Angiotensin 2
Angiotensin II (human)
 
Angiotensin II (mouse)
Angiotonin
Asp-arg-val-TYR-ile-his-pro-phe
Human angiotensin II
Hypertensin
Ile(5)-angiotensin II
38Calcium, DietaryPhase 4, Phase 3, Phase 2, Phase 15525
39calcium channel blockersPhase 4, Phase 3, Phase 21940
40Antihypertensive AgentsPhase 4, Phase 3, Phase 24095
41
protease inhibitorsPhase 4, Phase 3, Phase 2, Phase 15320
Synonyms:
 
protease inhibitors
42Neurotransmitter AgentsPhase 4, Phase 3, Phase 2, Phase 117734
43HIV Protease InhibitorsPhase 4, Phase 3, Phase 2, Phase 15319
44Autonomic AgentsPhase 4, Phase 3, Phase 2, Phase 19774
45Adrenergic beta-AntagonistsPhase 4, Phase 31154
46AntiemeticsPhase 4, Phase 3, Phase 23888
47Antineoplastic Agents, HormonalPhase 4, Phase 3, Phase 25407
48AntimetabolitesPhase 4, Phase 3, Phase 2, Phase 111774
49Antidepressive AgentsPhase 4, Phase 3, Phase 22666
50insulinPhase 4, Phase 34524

Interventional clinical trials:

(show top 50)    (show all 378)
idNameStatusNCT IDPhase
1Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki DiseaseCompletedNCT01524939Phase 4
2Kanagawa Valsartan Trial (KVT): Effects of Valsartan on Renal and Cardiovascular DiseaseCompletedNCT00190580Phase 4
3Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese PatientsCompletedNCT01325935Phase 4
4Efficacy, Safety and Tolerability of Rivastigmine Patch in Patients With Mild to Moderate Alzheimer's Disease Switched From Cholinesterase InhibitorsCompletedNCT01529619Phase 4
5The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study)CompletedNCT00250380Phase 4
6INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic NephropathyCompletedNCT00153088Phase 4
7PROs in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With PregabalinCompletedNCT02273908Phase 4
8Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese PatientsCompletedNCT01190007Phase 4
9A Multi-center, Randomized to Compare the Efficacy of IVIG Alone and IVIG Plus High-dose Aspirin in Kawasaki DiseaseRecruitingNCT02951234Phase 4
10The Preventive Implantation of Bioresorbable Vascular Scaffold on Functionally Insignificant Stenosis With Vulnerable Plaque CharacteristicsRecruitingNCT02316886Phase 4
11Low-dose Glucocorticoid Vasculitis Induction StudyRecruitingNCT02198248Phase 4
12Study of the QOL Evaluation of Trelagliptin in Patients With Type 2 Diabetes MellitusRecruitingNCT03014479Phase 4
13Efficacy and Safety Study of Empagliflozin as add-on to Insulin in Japanese Patients With Type 2 Diabetes MellitusRecruitingNCT02589639Phase 4
14A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP)RecruitingNCT02417935Phase 4
15Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)Active, not recruitingNCT01897532Phase 4
16Long-term Safety and Efficacy of Empagliflozin as Add on to GLP-1 RAActive, not recruitingNCT02589626Phase 4
17S-1 or Tegafur-Uracil in Treating Patients With Previously Treated Stage III or Stage IV Head and Neck CancerUnknown statusNCT00336947Phase 3
18Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCCUnknown statusNCT01214343Phase 3
19Infliximab for Kawasaki Disease Patients Resistant to IVIG : a Multicentre, Prospective, Randomised TrialCompletedNCT02298062Phase 3
20Different Doses of IVIG for Kawasaki DiseaseCompletedNCT02439996Phase 3
21A Study to Evaluate the Use and Safety of CARDIOLITE® in Pediatric Patients With Kawasaki DiseaseCompletedNCT00162032Phase 3
22Infliximab Plus Intravenous Immunoglobulin for the Primary Treatment of Kawasaki DiseaseCompletedNCT00760435Phase 3
23Clinical Study of TA-650 in Patients With Refractory Kawasaki DiseaseCompletedNCT01596335Phase 3
24Trial of Pulse Steroid Therapy in Kawasaki Disease--Pediatric Heart NetworkCompletedNCT00132080Phase 3
25Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency DisordersCompletedNCT00157079Phase 3
26An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune ThrombocytopeniaCompletedNCT02063789Phase 3
27Treatment of Childhood Onset Psychiatric Disorders With Intravenous Immunoglobulin (IVIg)CompletedNCT00001768Phase 3
28Acarbose and Secondary Prevention After Coronary StentingCompletedNCT00221156Phase 3
29Randomized, Double-blind Study to Evaluate the Tolerability of 2 Different Titration Methods of Rivastigmine Patch in AD Patients (MMSE 10-20)CompletedNCT01614886Phase 3
30A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease ParticipantsCompletedNCT02337738Phase 2, Phase 3
31Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00876694Phase 3
32Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00794157Phase 3
33A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease ParticipantsCompletedNCT02337764Phase 3
34Long Term Safety and Tolerability of QVA149 Versus Tiotropium in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01285492Phase 3
35Efficacy and Safety Study of Symbicort® Turbuhaler® Versus Oxis® Turbuhaler® in Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01069289Phase 3
36Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT01047553Phase 3
37Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By SurgeryCompletedNCT00392899Phase 3
38A Phase 3 Study of SME3110 in Pediatric/Adolescent Subjects With Obsessive Compulsive DisorderCompletedNCT01933919Phase 3
39Compare the Efficacy and Safety of Donepezil Hydrochloride 23 mg Treatment With Continuation of Donepezil Hydrochloride 10 mg Treatment in Japanese Subjects With Severe Alzheimer's DiseaseCompletedNCT01539031Phase 3
40Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EUCompletedNCT00628862Phase 3
41Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)CompletedNCT01441440Phase 3
42Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive DisorderCompletedNCT01355081Phase 3
43Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01431287Phase 3
44Long Term Safety and Tolerability of NVA237 Versus Tiotropium in Japanese PatientsCompletedNCT01119937Phase 3
45Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive DisorderCompletedNCT01395147Phase 3
46Tolvaptan Phase 3 Efficacy and Safety Study in ADPKDCompletedNCT00428948Phase 3
47Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)CompletedNCT01485887Phase 3
48A Phase 3 Study Of Intravenous Metronidazole For Intrabdominal InfectionCompletedNCT01473836Phase 3
49Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast CancerCompletedNCT00248170Phase 3
50Efficacy, Safety, and Tolerability of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Bipolar I PatientsCompletedNCT01567527Phase 3

Search NIH Clinical Center for Kawasaki Disease


Cochrane evidence based reviews: mucocutaneous lymph node syndrome

Genetic Tests for Kawasaki Disease

About this section

Genetic tests related to Kawasaki Disease:

id Genetic test Affiliating Genes
1 Acute Febrile Mucocutaneous Lymph Node Syndrome27
2 Kawasaki Disease, Susceptibility to24 ITPKC

Anatomical Context for Kawasaki Disease

About this section

MalaCards organs/tissues related to Kawasaki Disease:

36
Heart, Lymph node, Tongue, Skin, Eye, Endothelial, Lung

FMA organs/tissues related to Kawasaki Disease:

17
Body

Publications for Kawasaki Disease

About this section

Articles related to Kawasaki Disease:

(show top 50)    (show all 1076)
idTitleAuthorsYear
1
The serum concentration of soluble interleukin-2 receptor in patients with Kawasaki disease. (28081636)
2017
2
High-dose aspirin for Kawasaki disease: outdated myth or effective aid? (28079513)
2017
3
Anti-inflammatory effect of resveratrol in human coronary arterial endothelial cells via induction of autophagy: implication for the treatment of Kawasaki disease. (28069066)
2017
4
Pathogenetic determinants in Kawasaki disease: the haematological point of view. (28063205)
2017
5
Prediction of Resistance to Intravenous Immunoglobulin in Children With Kawasaki Disease. (28062554)
2017
6
Identifying genetic hypomethylation and upregulation of toll-like receptors in Kawasaki disease. (28061462)
2017
7
Intravenous Immunoglobulin for the Treatment of Kawasaki Disease. (28079915)
2017
8
Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment. (28089146)
2017
9
Aggressive anti-inflammatory treatment for refractory Kawasaki disease. (27592262)
2016
10
Pro-brain natriuretic peptide (ProBNP) levels in North Indian children with Kawasaki disease. (26849890)
2016
11
Hemophagocytosis in the Acute Phase of Fatal Kawasaki Disease in a 4 Month-Old Girl. (27606147)
2016
12
Cervical US and CT findings of Kawasaki disease: comparison with lymphadenitis. (27097838)
2016
13
Giant Coronary Aneurysms in a one-month-old Infant with Kawasaki Disease. (27641973)
2016
14
Genome-Wide Association Study Identifies Novel Susceptibility Genes Associated with Coronary Artery Aneurysm Formation in Kawasaki Disease. (27171184)
2016
15
Proteomic analysis associated with coronary artery dilatation caused by Kawasaki disease using serum exosomes. (27118092)
2016
16
Significance of serum 25-hydroxyvitamin D3 and interleukin-6 levels in immunoglobulin treatment of Kawasaki disease in children. (27602072)
2016
17
Losartan attenuates the coronary perivasculitis through its local and systemic anti-inflammatory properties in a murine model of Kawasaki disease. (27997528)
2016
18
Endothelial microparticles induce vascular endothelial cell injury in children with Kawasaki disease. (27212174)
2016
19
Suppressive influence of seasonal influenza epidemic on Kawasaki disease onset. (28049962)
2016
20
Interleukin-4 cytokine single nucleotide polymorphisms in kawasaki disease: a case-control study and a review of knowledge. (28036156)
2016
21
Kawasaki Disease With Coronary Artery Aneurysms: Psychosocial Impact on Parents and Children. (28027841)
2016
22
A 2-month-old boy with hemolytic anemia and reticulocytopenia following intravenous immunoglobulin therapy for Kawasaki disease: a case report and literature review. (28018448)
2016
23
Usefulness of Single Photon Emission Computed Tomography/Computed Tomography Fusion-Hybrid Imaging to Evaluate Coronary Artery Disorders in Patients with a History of Kawasaki Disease. (27180792)
2016
24
Clinical outcome of patients with refractory Kawasaki disease based on treatment modalities. (27610181)
2016
25
Four cases with Kawasaki disease and viral infection: aetiology or association. (28011972)
2016
26
GM-CSF primes cardiac inflammation in a mouse model of Kawasaki disease. (27595596)
2016
27
Aortic root aneurysm extending into the arch as a rare complication of Kawasaki disease: surgical management. (28040678)
2016
28
Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population. (27633390)
2016
29
ST-elevation myocardial infarction in a young adult secondary to giant coronary aneurysm thrombosis: an important sequela of Kawasaki disease and a management challenge. (26791126)
2016
30
Revisiting the role of environmental and climate factors on the epidemiology of Kawasaki disease. (27603178)
2016
31
Should 2016 Criteria for Macrophage Activation Syndrome be applied in children with Kawasaki disease, as well as with systemic-onset juvenile idiopathic arthritis? (26965982)
2016
32
Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention after Kawasaki Disease: The Pediatric Canadian Series. (27663723)
2016
33
Recurrent Kawasaki Disease: Mind the Age, But It Does Not Matter. (27219316)
2016
34
Galectin-3 and Kawasaki disease patients with special reference to coronary artery aneurysm. (26595790)
2016
35
Myocardial Strain and Strain Rate in Kawasaki Disease: Range, Recovery, and Relationship to Systemic Inflammation/Coronary Artery Dilation. (27182455)
2016
36
One small step for exosomes, one giant leap for Kawasaki disease. (27132470)
2016
37
TNF-I+ induces vascular endothelial cells apoptosis through overexpressing pregnancy induced noncoding RNA in Kawasaki disease model. (26794462)
2016
38
Crystalline keratopathy due to intravenous immunoglobulin in a 12-year-old girl with Kawasaki disease. (27667371)
2016
39
Kawasaki disease associated with Mycoplasma pneumoniae. (27609267)
2016
40
Establishment of Kawasaki disease database based on metadata standard. (27630202)
2016
41
Cardiac Complications in 38 Cases of Kawasaki Disease with Coronary Artery Aneurysm Diagnosed by Echocardiography. (26711003)
2016
42
Factors Associated With Resource Utilization and Coronary Artery Dilation in Refractory Kawasaki Disease (from the Pediatric Health Information System Database). (27665207)
2016
43
Kawasaki disease with unusual clinical course in a young infant: case report and perspective management suggestion. (27125442)
2016
44
Role of triggering receptor expressed on myeloid cells-1 in the pathogenesis of Kawasaki disease]. (27324541)
2016
45
A 5-year-old boy with only fever and giant coronary aneurysms: the enigma of Kawasaki disease? (27154559)
2016
46
Importance of anatomical dominance in the evaluation of coronary dilatation in Kawasaki disease. (27640521)
2016
47
Notch4 Signaling Pathway of Endothelial Progenitor Cells in a Kawasaki Disease Model Induced by Lactobacillus casei Cell Wall Extract. (28013300)
2016
48
Corticosteroid Therapy Might be Associated with the Development of Coronary Aneurysm in Children with Kawasaki Disease. (27064036)
2016
49
Severe Hemolytic Anemia Following Intravenous Immunoglobulin in an Infant With Kawasaki Disease. (27879540)
2016
50
Preventing Long-Term Cardiac Damage in Pediatric Patients With Kawasaki Disease. (27592169)
2016

Variations for Kawasaki Disease

About this section

Clinvar genetic disease variations for Kawasaki Disease:

5
id Gene Variation Type Significance SNP ID Assembly Location
1ARNM_000044.3(AR): c.172_174CAG(10_36) (p.Gln69_Gln80del)NT expansionPathogenicrs193922933GRCh37Chr X, 66765160: 66765162

Expression for genes affiliated with Kawasaki Disease

About this section
Search GEO for disease gene expression data for Kawasaki Disease.

Pathways for genes affiliated with Kawasaki Disease

About this section

Pathways related to Kawasaki Disease according to GeneCards Suite gene sharing:

(show all 29)
idSuper pathwaysScoreTop Affiliating Genes
19.9CCL2, IL6, MMP9
29.9MMP3, MMP9, TIMP1
3
Show member pathways
9.9CRP, IL6, TIMP1
49.9AR, IL6, TNF
5
Show member pathways
9.7CCL2, MMP3, MMP9, TIMP1
69.7IL10, IL6, TNF
79.7IL10, IL6, TNF
89.7CCL2, IL6, SELE, TNF
99.6ELANE, IL6, MMP9, TNF
109.6ELANE, IL6, MMP3, MMP9
119.6HSPD1, IL6, MYD88, TNF
129.6FCGR2A, IL10, MBL2
139.6CCL2, IL6, MMP3, TNF
149.5CCL2, IL10, IL6, TNF
159.5IL10, IL6, MYD88, TNF
16
Show member pathways
9.5ELANE, MMP3, MMP9, TIMP1, TNF
17
Show member pathways
9.5FCGR2A, IL10, MYD88, TNF
189.4ELANE, MMP3, MMP9, SELE, SELL
199.4IL10, IL6, SELL, TNF
209.4FCGR2A, IL10, IL6, TNF
219.4CCL2, FCGR2A, IL6, MMP9, TNF
229.3AR, HSPD1, IL10, IL6, TNF
23
Show member pathways
9.3CCL2, IL10, IL6, TIMP1, TNF
249.3IL10, IL6, MYD88, SELE, TNF
259.3CCL2, IL6, MMP3, MMP9, SELE, TNF
26
Show member pathways
9.2CCL2, IL10, IL6, MMP9, MYD88, TNF
279.2CCL2, IL10, IL6, MYD88, SELE, TNF
289.1FCGR2A, IL10, IL6, SELL, TNF
299.0FCGR2A, HSPD1, IL10, IL6, MYD88, TNF

GO Terms for genes affiliated with Kawasaki Disease

About this section

Cellular components related to Kawasaki Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1protein complexGO:00432349.5ALB, AR, HSPD1, MYD88, NPPB
2extracellular regionGO:00055768.7ALB, CCL2, CRP, ELANE, IL6, MBL2
3extracellular spaceGO:00056158.1ALB, CCL2, CRP, ELANE, HSPD1, IL10

Biological processes related to Kawasaki Disease according to GeneCards Suite gene sharing:

(show all 37)
idNameGO IDScoreTop Affiliating Genes
1opsonizationGO:000822810.8CRP, MBL2
2epithelial cell proliferation involved in salivary gland morphogenesisGO:006066410.8IL6, TNF
3positive regulation of chemokine biosynthetic processGO:004508010.8MYD88, TNF
4positive regulation of interleukin-8 biosynthetic processGO:004541610.7ELANE, TNF
5negative regulation of chemokine biosynthetic processGO:004507910.7ELANE, IL6
6regulation of vascular endothelial growth factor productionGO:001057410.7CCL2, IL6
7negative regulation of membrane protein ectodomain proteolysisGO:005104510.7IL10, TIMP1
8leukocyte migration involved in inflammatory responseGO:000252310.6CCL2, ELANE, SELE
9positive regulation of macrophage activationGO:004303210.6HSPD1, IL10
10positive regulation of inflammatory responseGO:005072910.6CCL2, HSPD1, S100A12
11negative regulation of cytokine secretion involved in immune responseGO:000274010.6IL10, TNF
12monocyte chemotaxisGO:000254810.6CCL2, IL6, S100A12
13lipopolysaccharide-mediated signaling pathwayGO:003166310.6CCL2, MYD88, TNF
14acute-phase responseGO:000695310.6CRP, IL6, MBL2
15receptor biosynthetic processGO:003280010.6IL10, TNF
16humoral immune responseGO:000695910.6CCL2, IL6, TNF
17positive regulation of MAP kinase activityGO:004340610.6ELANE, S100A12, TNF
18negative regulation of lipid storageGO:001088810.6CRP, IL6, TNF
19response to heatGO:000940810.5CCL2, HSPD1, IL6
20extracellular matrix disassemblyGO:002261710.4ELANE, MMP3, MMP9, TIMP1
21response to activityGO:001482310.4CCL2, HSPD1, IL10
22agingGO:000756810.3CCL2, IL10, IL6, TIMP1
23positive regulation of interleukin-6 productionGO:003275510.3HSPD1, IL6, MYD88, TNF
24cellular response to lipopolysaccharideGO:007122210.3CCL2, IL10, IL6, TNF
25positive regulation of smooth muscle cell proliferationGO:004866110.3ELANE, IL6, MYD88, TNF
26response to peptidoglycanGO:003249410.2IL6, MYD88
27positive regulation of NF-kappaB transcription factor activityGO:005109210.2AR, IL6, MYD88, S100A12, TNF
28leukocyte migrationGO:005090010.2ELANE, MMP9, SELE, SELL, TNF
29defense response to Gram-positive bacteriumGO:005083010.2CRP, IL6, MBL2, MYD88, TNF
30defense response to bacteriumGO:004274210.1ELANE, IL10, MBL2, S100A12, TNF
31response to yeastGO:000187810.0ELANE, IL6
32negative regulation of growth of symbiont in hostGO:004413010.0ELANE, IL10, MBL2, MYD88, TNF
33response to glucocorticoidGO:00513849.9CCL2, HSPD1, IL10, IL6, TNF
34inflammatory responseGO:00069549.6CCL2, CRP, IL10, IL6, MYD88, S100A12
35negative regulation of apoptotic processGO:00430669.6ALB, HSPD1, IL10, IL6, MMP9, MYD88
36response to organic substanceGO:00100339.5ALB, HSPD1, IL10, TIMP1, TNF
37response to lipopolysaccharideGO:00324969.5CCL2, ELANE, HSPD1, IL10, IL6, MYD88

Molecular functions related to Kawasaki Disease according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1endopeptidase activityGO:000417510.7ELANE, MMP3, MMP9
2protease bindingGO:000202010.2ELANE, HSPD1, SELL, TIMP1, TNF
3cytokine activityGO:000512510.2CCL2, IL10, IL6, TIMP1, TNF
4receptor bindingGO:00051029.9AR, CCL2, IL6, MBL2, MYD88, NPPB
5serine-type endopeptidase activityGO:00042529.6ELANE, MBL2, MMP3, MMP9
6protein bindingGO:00055157.0ALB, AR, CCL2, CRP, ELANE, FCGR2A

Sources for Kawasaki Disease

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet